Related Experiment Video

Updated: Jun 30, 2026

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

Transdermal buprenorphine in children with cancer-related pain

Giorgio Attinà1, Antonio Ruggiero, Palma Maurizi

  • 1Division of Paediatric Oncology, Catholic University, Rome, Italy. gioatt@hotmail.com

Pediatric Blood & Cancer
|September 20, 2008
PubMed

Insights

Transdermal Buprenorphine effectively managed cancer-related pain in young children (3-5 years). This treatment reduced pain scores and medication use, improving sleep quality with minimal side effects.

Area of Science:

  • Pediatric Oncology
  • Pain Management
  • Pharmacology

Background:

  • Cancer-related pain is a significant challenge in pediatric oncology.
  • Effective pain management is crucial for improving quality of life in children with cancer.
  • Limited data exists on Transdermal Buprenorphine use in pediatric populations.

Observation:

  • Three children aged 3-5 years with cancer-related pain were treated with Transdermal Buprenorphine.
  • Pain was assessed using a visual analog scale.
  • The need for additional pain medications, particularly opioids, was evaluated.

Findings:

  • Transdermal Buprenorphine demonstrated adequate analgesia in all three pediatric cases.
  • Pain scores decreased significantly with treatment.
  • A reduction in overall medication, including opioids, was observed.
  • Patients experienced improved uninterrupted sleep.

Implications:

  • Transdermal Buprenorphine offers a viable option for managing cancer pain in young children.
  • This approach may reduce reliance on other analgesics, potentially lowering side effect burdens.
  • Further research is warranted to confirm efficacy and safety in larger pediatric cohorts.

More Related Videos

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat13:27

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat

Published on: October 6, 2018

Identification and Analysis of Myogenic Progenitors In Vivo During Acute Skeletal Muscle Injury by High-Dimensional Single-Cell Mass Cytometry11:02

Identification and Analysis of Myogenic Progenitors In Vivo During Acute Skeletal Muscle Injury by High-Dimensional Single-Cell Mass Cytometry

Published on: December 1, 2023

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...